{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T01:32:40Z","timestamp":1772933560573,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,9,9]],"date-time":"2027-09-09T00:00:00Z","timestamp":1820448000000},"content-version":"am","delay-in-days":616,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006134","name":"Foundation for Promotion of Material Science and Technology of Japan","doi-asserted-by":"publisher","award":["19H05458"],"award-info":[{"award-number":["19H05458"]}],"id":[{"id":"10.13039\/501100006134","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010002","name":"Ministry of Education","doi-asserted-by":"publisher","award":["MOE-108-YSFMS-0004\\u2013012-P1"],"award-info":[{"award-number":["MOE-108-YSFMS-0004\\u2013012-P1"]}],"id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.colsurfb.2025.115120","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T18:13:26Z","timestamp":1757096006000},"page":"115120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Valproic acid-based self-assembling nanoparticle prodrugs prevent skeletal muscle loss in cancer cachexia"],"prefix":"10.1016","volume":"257","author":[{"given":"Shoki","family":"Kamemaru","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7975-6510","authenticated-orcid":false,"given":"Yukio","family":"Nagasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2025.115120_bib1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41568-020-0251-4","article-title":"Understanding cachexia in the context of metastatic progression","volume":"20","author":"Biswas","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.colsurfb.2025.115120_bib2","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: understanding the molecular basis","volume":"14","author":"Argil\u00e9s","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.colsurfb.2025.115120_bib3","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"2","key":"10.1016\/j.colsurfb.2025.115120_bib4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.colsurfb.2025.115120_bib5","doi-asserted-by":"crossref","first-page":"C101","DOI":"10.1152\/ajpcell.00344.2015","article-title":"Valproic acid attenuates skeletal muscle wasting by inhibiting C\/EBP-regulated atrogin1 expression in cancer cachexia","volume":"311","author":"Sun","year":"2016","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"15","key":"10.1016\/j.colsurfb.2025.115120_bib6","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.clinbiochem.2013.06.012","article-title":"Adverse drug reactions induced by valproic acid","volume":"46","author":"Nanau","year":"2013","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.colsurfb.2025.115120_bib7","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41398-022-01898-x","article-title":"Human forebrain organoids reveal connections between valproic acid exposure and autism risk","volume":"12","author":"Meng","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.colsurfb.2025.115120_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122047","article-title":"Self-assembling polymer-based short chain fatty acid prodrugs ameliorate non-alcoholic steatohepatitis and liver fibrosis","volume":"Volume 295","author":"Shashni","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2025.115120_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.102103","article-title":"Self-assembling butyric acid prodrug acts as a sensitizer for cancer radiotherapy","volume":"Volume 54","author":"Shashni","year":"2024","journal-title":"Nano Today"},{"issue":"21","key":"10.1016\/j.colsurfb.2025.115120_bib10","doi-asserted-by":"crossref","first-page":"5745","DOI":"10.1021\/acs.langmuir.0c00420","article-title":"Surfactant Self-Assembling and critical micelle concentration: one approach fits all?","volume":"36","author":"Perinelli","year":"2020","journal-title":"Langmuir"},{"key":"10.1016\/j.colsurfb.2025.115120_bib11","doi-asserted-by":"crossref","DOI":"10.1039\/D2BM01064J","article-title":"Design of self-assembling anti-epileptic drug for long-acting drug delivery in vivo","author":"Ikeda","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.colsurfb.2025.115120_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202301159","article-title":"Design of antioxidant nanoparticle, which selectively locates and scavenges reactive oxygen species in the gastrointestinal tract, increasing the running time of mice","volume":"10","author":"Toriumi","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.colsurfb.2025.115120_bib13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/1471-2407-10-363","article-title":"Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse","volume":"10","author":"Aulino","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.colsurfb.2025.115120_bib14","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.freeradbiomed.2015.12.031","article-title":"The role of E3 ubiquitin-ligases MuRF-1 and MAFbx in loss of skeletal muscle mass","volume":"Volume 98","author":"Rom","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.colsurfb.2025.115120_bib15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13045-023-01454-0","article-title":"Cancer cachexia: molecular mechanisms and treatment strategies","volume":"16","author":"Setiawan","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.colsurfb.2025.115120_bib16","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1186\/s12885-018-5080-4","article-title":"Pharmacological management of cachexia in adult cancer patients: a systematic review of clinical trials","volume":"18","author":"Advani","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.colsurfb.2025.115120_bib17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.21608\/ajfm.2013.19412","article-title":"Influence of silymarin on valproic acid induced hepatotoxicity in adult Male albino rats","volume":"20","author":"El-Khateeb","year":"2013","journal-title":"Ain Shams J. Forensic Med. Clin. Toxicol."},{"issue":"10","key":"10.1016\/j.colsurfb.2025.115120_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141610","article-title":"Limited effect of chronic valproic acid treatment in a mouse model of Machado-Joseph disease","volume":"10","author":"Esteves","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.colsurfb.2025.115120_bib19","doi-asserted-by":"crossref","first-page":"7383","DOI":"10.16965\/ijar.2020.108","article-title":"VALPROATE INDUCED NEPHROTOXICITY ON FETAL MICE KIDNEY","volume":"8","author":"Shakya","year":"2020","journal-title":"Int. J. Anat. Res."},{"key":"10.1016\/j.colsurfb.2025.115120_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120877","article-title":"Design of enzyme-responsive short-chain fatty acid-based self-assembling drug for alleviation of type 2 diabetes mellitus","volume":"Volume 275","author":"Shashni","year":"2021","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.colsurfb.2025.115120_bib21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1517\/14656566.9.2.285","article-title":"Oral valproic acid for epilepsy - long-term experience in therapy and side effects","volume":"9","author":"Gerstner","year":"2008","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.colsurfb.2025.115120_bib22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00424-010-0919-9","article-title":"The role and regulation of MAFbx\/atrogin-1 and MuRF1 in skeletal muscle atrophy","volume":"461","author":"Foletta","year":"2011","journal-title":"Pflug. Arch. Eur. J. Physiol."},{"key":"10.1016\/j.colsurfb.2025.115120_bib23","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1096\/fj.05-5249fje","article-title":"Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in akt and an increase in Atrogin-1","volume":"20","author":"L\u00e9ger","year":"2006","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.colsurfb.2025.115120_bib24","first-page":"225","article-title":"Signaling pathways perturbing muscle mass","volume":"13","author":"Glass","year":"2010","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.colsurfb.2025.115120_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.colsurfb.2025.115120_bib26","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.3390\/cancers14092107","article-title":"Molecular mechanisms and current treatment options for cancer cachexia","volume":"14","author":"Ahmad","year":"2022","journal-title":"Cancers"}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776525006277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776525006277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T06:46:14Z","timestamp":1772865974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776525006277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":26,"alternative-id":["S0927776525006277"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2025.115120","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valproic acid-based self-assembling nanoparticle prodrugs prevent skeletal muscle loss in cancer cachexia","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2025.115120","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115120"}}